Candriam S.C.A. Cogent Biosciences, Inc. Transaction History

Candriam S.C.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.06 - $10.08 $2.21 Million - $5.49 Million	-545,000 Reduced 70.1%	232,487 $1.37 Million
Q3 2023 Nov 13, 2023	BUY	$9.69 - $13.34 $48,450 - $66,700	5,000 Added 0.65%	777,487 $7.58 Million
Q2 2023 Aug 08, 2023	SELL	$9.85 - $13.24 $1.62 Million - $2.18 Million	-164,654 Reduced 17.57%	772,487 $9.15 Million
Q1 2023 May 12, 2023	SELL	$10.04 - $15.5 $602,400 - $930,000	-60,000 Reduced 6.02%	937,141 $10.1 Million
Q4 2022 Feb 13, 2023	SELL	$10.65 - $14.84 $1.64 Million - $2.29 Million	-154,361 Reduced 13.41%	997,141 $11.5 Million
Q3 2022 Nov 10, 2022	SELL	$9.39 - $16.99 $933,243 - $1.69 Million	-99,387 Reduced 7.95%	1,151,502 $17.2 Million
Q2 2022 Aug 03, 2022	SELL	$3.92 - $9.73 $1.97 Million - $4.89 Million	-502,091 Reduced 28.64%	1,250,889 $11.3 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.7 $598,925 - $981,290	-112,792 Reduced 6.05%	1,752,980 $13.1 Million
Q4 2021 Feb 10, 2022	SELL	$7.51 - $10.81 $461,692 - $664,566	-61,477 Reduced 3.19%	1,865,772 $16 Million
Q3 2021 Nov 09, 2021	BUY	$5.99 - $9.14 $99,008 - $151,075	16,529 Added 0.87%	1,927,249 $16.2 Million
Q2 2021 Jul 20, 2021	BUY	$7.82 - $9.3 $11.2 Million - $13.4 Million	1,435,911 Added 302.42%	1,910,720 $15.5 Million
Q1 2021 Apr 29, 2021	BUY	$7.47 - $12.34 $590 - $974	79 Added 0.02%	474,809 $5.12 Million
Q4 2020 Jan 22, 2021	BUY	$9.04 - $13.01 $4.29 Million - $6.18 Million	474,730 New	474,730 $5.33 Million

172

114M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $612M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.